key: cord-0726125-bsnepvq0 authors: Wu, Zhonglan; Harrich, David; Li, Zhongyang; Hu, Dongsheng; Li, Dongsheng title: The unique features of SARS‐CoV‐2 transmission: Comparison with SARS‐CoV, MERS‐CoV and 2009 H1N1 pandemic influenza virus date: 2020-09-18 journal: Rev Med Virol DOI: 10.1002/rmv.2171 sha: ac7765edf258d61f7773d423a3d9b9963f26a52c doc_id: 726125 cord_uid: bsnepvq0 From 2002 to 2019, three deadly human coronaviruses (hCoVs), severe acute respiratory syndrome coronavirus (SARS‐CoV), Middle Eastern respiratory syndrome coronavirus (MERS‐CoV) and severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) emerged to produce outbreaks of SARS, MERS and coronavirus disease 2019 (Covid‐19), respectively. All three hCoVs are members of the Betacoronavirus genus in the subfamily Orthocoronavirinae and share many similarities in virology and epidemiology. However, the pattern and scale of Covid‐19 global spread is similar to 2009 pandemic H1N1 influenza (H1N1pdm09), rather than SARS or MERS. Covid‐19 exhibits high viral shedding in the upper respiratory tract at an early stage of infection, and has a high proportion of transmission competent individuals that are pre‐symptomatic, asymptomatic and mildly symptomatic, characteristics seen in H1N1pdm09 but not in SARS or MERS. These two traits of Covid‐19 and H1N1pdm09 result in reduced efficiency in identification of transmission sources by symptomatic screening and play important roles in their ability to spread unchecked to cause pandemics. To overcome these attributes of Covid‐19 in community transmission, identifying the transmission source by testing for virus shedding and interrupting chains of transmission by social distancing and public masking are required. were reported globally to the World Health Organization (WHO) and 866 associated deaths were recorded with a case-fatality rate of 34.3%. 3 The most recent emerged human coronavirus (hCoV), severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was first identified in Wuhan city, Hubei province, China in December 2019 and has caused the ongoing global pandemic of Coronavirus Disease 2019 . 4 In the first 4 months outbreak by 1 April 2020, there were 823,626 confirmed cases and 40,598 deaths in 205 countries and territories. 5 These CoVs belong to the subfamily Orthocoronavirinae in the family Coronaviridae of the order Nidovirales. The subfamily includes four genera: α, β, γ and δ-CoVs. All three of SARS-CoV, MERS-CoV and SARS-CoV-2 belong to the β-CoV genera and are reported to originate from bats. 9 The genetic similarity of SARS-CoV-2 to SARS-CoV and MERS-CoV is 79% and 50%, respectively. 10 The virus particles of CoVs are approximately and nucleocapsid (N). The N protein enshrouds the RNA genome while the S, E and M proteins together assemble in the viral envelope. 10, 11 The S protein is a large multifunctional class I viral transmembrane protein that lies on the virion surface imparting a halo-or crown-like appearance when viewed by electron microscopy. 12 The viral S protein mediates attachment and fusion of the viral and cellular plasma membranes, leading to viral entry. Therefore, S protein is a critical determinant of host range and tissue tropism. 12, 13 The S proteins of SARS-CoV-2 and SARS-CoV are phylogenetically and closely related with an amino acid sequence identity of 77%. Both proteins directly bind to and use angiotensin-converting enzyme-2 (ACE2) as a cell receptor and the binding affinity of SARS-CoV-2 S protein with ACE2 is 10 to 20-fold higher than that of SARS-CoV S protein, indicating that SARS-CoV-2 infects the same types of host cells as SARS-CoV, but with a higher efficiency. 11,14-16 MERS-CoV and H1N1pdm09 employ dipeptidyl peptidase 4 (DPP4) and α2,6 sialic acids as a receptor for cell entry, respectively. [17] [18] [19] While these cellular receptors distribute in the respiratory tract to serve the original viral entry, ACE2 and DPP4 are expressed more broadly in various tissue and organs ( Aerosol transmission was reported to have an important role in the spread of SARS-CoV, MERS-CoV, SARS-CoV-2 and influenza viruses. 21 Aerosols are droplets of less than 5 µm that can remain airborne for a prolonged period of time. 22 In experimental conditions, dynamic aerosol efficiency of SARS-CoV-2 surpassed those of SARS-CoV and MERS-CoV, and respirable-sized aerosols of SARS-CoV-2 retained infectivity and virion integrity for up to 16 h. 23 Although coughing and sneezing produce more aerosols per breathing manoeuvre than normal breathing, normal breathing can generate aerosols, 24 implying the transmission competency of pre-symptomatic, asymptomatic and mild infections. The incubation period, defined as the number of days from virus exposure to symptom onset, is similar among these three hCoVs, and shorter for H1N1pdm09 (Table 1 ). Reproduction number R0 is defined as the number of secondary cases resulting from a single initial case and is an index of viral infectiousness. 25 The R0 value of a spreading virus is dynamic during an outbreak and affected by numerous biological, sociobehavioral and environmental factors. 26 R0 value at early stage of an outbreak, prior to implementation of interventions, is an indicator of viral infectiousness, while the R0 value at later stages of outbreak is generally more a reflection of the effectiveness of control measures. R0 values are also greatly affected by the calculation methods 27 and the nature of transmission events, such as an outbreak in a healthcare settings, in an aircraft and by superspreading events. [28] [29] [30] The R0 values for SARS-CoV, MERS-CoV, SARS-CoV-2 and H1N1pdm09 varied considerably between different studies, which complicate comparisons between these viruses. In 12 studies by 7 February 2020, the R0 of SARS-CoV-2 ranged from 1.4 to 6.9, with a mean of 3.28 and a median of 2.79 27 Serial interval is an epidemiological term used to describe the time between successive cases in a string of transmissions from a primary case symptom onset to a secondary case symptom onset. If the observed mean serial interval is shorter than the observed mean of incubation period, this suggests that the transmission may have been caused by infected persons before symptom onset (pre-symptomatic transmission). The mean of serial interval of Covid-19 (3.95-7.5 days) 4 is shorter than SARS (8-12 days) and MERS (7-12 days; Table 1 ). Given the similar incubation periods of these three hCoVs, the short serial interval of Covid-19 indicates faster transmission of SARS-Cov-2 compared to SARS-CoV and MERS-CoV, and suggests that presymptomatic transmission is possible. Viral Figure 1c) . 37, 38 The highest positive rate of viral RNA from the respiratory tract by RT-PCR was detected in the first week after symptomatic onset and then declined. 37, 39 The duration of viral shedding in URT ranged 1-53.5 days and the aggregate duration of relative studies was 14.5 days. 40 The dynamics of viral shedding are not affected by disease severity, sex and age groups. 37 H1N1pdm09 infection has a shorter incubation period and viral shedding period compared to Covid-19, but they share a similar viral shedding dynamic. Viral shedding of H1N1pdm09 starts 1-3 days before symptom onset, peaks at 1-2 days and lasts around 1 week after symptom onset (Figure 1d ). [41] [42] [43] The cause of differences observed in virus shedding dynamics among these viruses is not completely understood but may relate There has been no reported instance of SARS transmission by a carrier before symptom onset. 51 Due to high levels of viral shedding in the early stage of infection and the shorter serial intervals compared to the incubation period ( Asymptomatic infections refer to individuals who are infected and Serological testing of 80 health workers in Singapore who were exposed to SARS cases prior to strict interdiction control measures showed 45 (56%) positive cases. Of the 45 positive cases, six (13%) were asymptomatic, two (4%) had subclinical illness and 37 (82%) had pneumonic SARS. 68 These studies indicate that asymptomatic infection of SARS is uncommon and the role in SARS transmission by asymptomatic infection is negligible. In Saudi Arabia, the seroprevalence of MERS-CoV specific antibody was significantly higher in persons who had occupational exposure to camels compared to the general population (camel shepherds, 2.3%; slaughterhouse workers, 3.6% and the general population 0.2%). 75 A similar study in Abu Dhabi (the United Arab Emirates) detected had an unknown exposure that may have involved transmission by asymptomatic virus carriers. 78 A study in Korea did not detect MERS-CoV transmission among 82 people that were exposed to an individual with asymptomatic or mild MERS-CoV infection. 79 In summary, asymptomatic infection of MERS-CoV is common, but transmission of MERS-CoV via asymptomatic infection has not been confirmed. Prospective studies of H1N1pdm09 outbreak involving households in Canada, Germany and Viet Nam reported the proportion of asymptomatic cases at 10%, 80 14% 81 and 45%, 42 respectively. Retrospective serological studies of the H1N1pdm09 outbreak revealed the proportion of asymptomatic infections were 45% in New Zealand and 84% in Austria. 82 Overall, asymptomatic infection by influenza is common. The role of asymptomatic transmission in influenza virus spread has not been conclusively demonstrated. One study showed that virus shedding dynamics in symptomatic and asymptomatic cases was similar, 42 while another study indicated that the titre of virus shedding was lower in paucisymptomatic and asymptomatic cases than in symptomatic cases 83 and infectivity of influenza was not associated with the titre of virus shedding. 84 week later while three remained asymptomatic. 87 All the authors declare that there is no existing commercial or financial conflict of interest, in any way. All the authors contributed to the information collection, analysis, writing and approving the final version of the manuscript. Dongsheng Li and Dongsheng Hu also contributed to planning and design. Data sharing not applicable to this article as no datasets were generated or analysed during the current study. The data that support the findings of this study are openly available in the cited reference. SARS and MERS: recent insights into emerging coronaviruses The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? WHO. Middle East respiratory syndrome coronavirus (MERS-CoV) -Qatar 2020 Early transmission dynamics in Wuhan, China, of Novel coronavirus-Infected pneumonia WHO. Coronavirus disease 2019 WHO. Coronavirus disease (COVID-19) situation report -189 Pandemic preparedness and response--lessons from the H1N1 influenza of 2009 Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study Bats are natural reservoirs of SARS-like coronaviruses A novel coronavirus from patients with pneumonia in China Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China Mechanisms of coronavirus cell entry mediated by the viral spike protein Structure, function, and evolution of coronavirus spike proteins Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses The first influenza pandemic of the new millennium. Influenza Other Respir Viruses Two years after pandemic influenza A/2009/H1N1: what have we learned? Airborne spread of SARS-CoV-2 and a potential role for air disinfection Aerosol transmission of influenza A virus: a review of new studies Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 Influenza virus in human exhaled breath: an observational study Superspreading and the effect of individual variation on disease emergence Complexity of the basic reproduction number (R0) The reproductive number of COVID-19 is higher compared to SARS coronavirus Severe acute respiratory syndrome coronavirus as an agent of emerging and re-emerging infection Identifying and interrupting superspreading events-implications for control of severe acute respiratory syndrome coronavirus 2 Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study Clinical characteristics of coronavirus disease 2019 in China Early diagnosis of SARS coronavirus infection by real time RT-PCR Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome Viral load kinetics of MERS coronavirus infection Middle East respiratory syndrome coronavirus infection dynamics and antibody responses among clinically diverse patients, Saudi Arabia Temporal dynamics in viral shedding and transmissibility of COVID-19 Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019 SARS-CoV-2 detection, viral load and infectivity over the course of an infection Viral load in patients infected with pandemic H1N1 2009 influenza A virus Pandemic H1N1 virus transmission and shedding dynamics in index case households prospective Vietnamese cohort Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age. Influenza Other Respiratory Viruses Virological assessment of hospitalized patients with COVID-2019 Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome Influenza A viruses are transmitted via the air from the nasal respiratory epithelium of ferrets Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention The severe acute respiratory syndrome Infectivity of severe acute respiratory syndrome during its incubation period Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea A locally transmitted case of SARS-CoV-2 infection in Taiwan A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period Potential presymptomatic transmission of SARS-CoV-2 Presymptomatic transmission of SARS-CoV-2 -Singapore Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster Asymptomatic and human-to-human transmission of SARS-CoV-2 in a 2-family cluster Serial interval of COVID-19 among publicly reported confirmed cases The timeline of influenza virus shedding in children and adults in a household transmission study of influenza in Managua Pandemic (H1N1) 2009 transmission during presymptomatic phase Pre-symptomatic transmission of pandemic influenza H1N1 2009: investigation of a family cluster Lack of evidence for presymptomatic transmission of pandemic influenza virus A(H1N1) 2009 in an outbreak among teenagers Viral dynamics in asymptomatic patients with COVID-19 Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship Asymptomatic SARS coronavirus infection among healthcare workers Risk factors for SARS infection within hospitals in Hanoi, Vietnam SARS-CoV antibody prevalence in all Hong Kong patient contacts Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens Risk-stratified seroprevalence of severe acute respiratory syndrome coronavirus among children in Hong Kong Absence of infection in asymptomatic contacts of index SARS case in France Seroprevalence of SARS coronavirus antibody in household contacts Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study Risk factors for MERS-CoV seropositivity among animal market and slaughterhouse workers Asymptomatic Middle East respiratory syndrome coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review Reported direct and indirect contact with dromedary camels among laboratory-confirmed MERS-CoV cases Infectivity of an asymptomatic patient with Middle East respiratory syndrome coronavirus infection Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratoryconfirmed secondary attack rates and evidence of asymptomatic infections Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1)pdm09 Pre-and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults Viral shedding and transmission potential of asymptomatic and paucisymptomatic influenza virus infections in the community Individual correlates of infectivity of influenza A virus infections in households A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster Asymptomatic cases in a family cluster with SARS-CoV-2 infection Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility -king county Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing Comparison of clinical characteristics of patients with asymptomatic vs symptomatic coronavirus disease 2019 in Wuhan, China Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los Angeles county, California Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China Presumed asymptomatic carrier transmission of COVID-19 Asymptomatic and pre-symptomatic cases of COVID-19 contribution to spreading the epidemic and need for targeted control strategies The epidemiological characteristics of infection in close contacts of COVID-19 in Ningbo city Epidemiology of COVID-19 among children in China Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV) Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak COVID-19: in the absence of vaccination -'mask-the-nation' Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan New measures for COVID-19 response: a lesson from the Wenzhou experience WHO. WHO coronavirus disease (COVID-19) dashboard 2020 Origin and evolution of pathogenic coronaviruses A pneumonia outbreak associated with a new coronavirus of probable bat origin Origins of the 2009 H1N1 influenza pandemic in swine in Mexico SARS and other coronaviruses as causes of pneumonia Does SARS-CoV-2 has a longer incubation period than SARS and MERS? Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks: mathematical modelling in Saudi Arabia and South Korea MERS transmission and risk factors: a systematic review Transmission dynamics and control of severe acute respiratory syndrome Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis An influenza A H1N1 virus revival -pandemic H1N1/09 virus The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus